Biotech · Private company
Emmaus Medical, Inc.
Track this companyFree. Adds Emmaus Medical, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- L-glutaminePhase 3 · Sickle Cell AnemiaClinicalTrials.gov · fetched Nov 12, 2026
- L-glutaminePhase 1 · Diverticulosis, ColonicClinicalTrials.gov · fetched Nov 12, 2026
- L-glutamineSickle Cell DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic CancerPHASE1 · COMPLETED · started May 13, 2021ClinicalTrials.gov NCT04634539 · fetched Nov 12, 2026
- Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease PatientsPHASE4 · COMPLETED · started Jan 4, 2021ClinicalTrials.gov NCT04684381 · fetched Nov 12, 2026
- L-glutamine Treatment in Patients With DiverticulosisPHASE1 · COMPLETED · started Jul 19, 2019ClinicalTrials.gov NCT05106101 · fetched Nov 12, 2026
- A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemiaPHASE3 · COMPLETED · started May 1, 2010ClinicalTrials.gov NCT01179217 · fetched Nov 12, 2026
- L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 ThalassemiaPHASE2 · COMPLETED · started Mar 1, 2004ClinicalTrials.gov NCT00125788 · fetched Nov 12, 2026